Logo image of AGH

AUREUS GREENWAY HOLDINGS INC (AGH) Stock Fundamental Analysis

NASDAQ:AGH - US05156D1028 - Common Stock

4.34 USD
+0.77 (+21.57%)
Last: 8/29/2025, 8:05:42 PM
4.44 USD
+0.1 (+2.3%)
After Hours: 8/29/2025, 8:05:42 PM
Fundamental Rating

3

AGH gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 131 industry peers in the Hotels, Restaurants & Leisure industry. While AGH has a great health rating, there are worries on its profitability. AGH does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year AGH has reported negative net income.
AGH had a negative operating cash flow in the past year.
AGH Yearly Net Income VS EBIT VS OCF VS FCFAGH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 200K 400K 600K 800K

1.2 Ratios

With a Return On Assets value of -1.94%, AGH is not doing good in the industry: 71.76% of the companies in the same industry are doing better.
With a Return On Equity value of -2.20%, AGH perfoms like the industry average, outperforming 49.62% of the companies in the same industry.
Industry RankSector Rank
ROA -1.94%
ROE -2.2%
ROIC N/A
ROA(3y)4.05%
ROA(5y)N/A
ROE(3y)17.5%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AGH Yearly ROA, ROE, ROICAGH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 20 40

1.3 Margins

With a Gross Margin value of 50.03%, AGH perfoms like the industry average, outperforming 56.49% of the companies in the same industry.
AGH's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for AGH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.76%
GM growth 5YN/A
AGH Yearly Profit, Operating, Gross MarginsAGH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 40

More info and screens

9

2. Health

2.1 Basic Checks

AGH does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AGH has been reduced compared to 1 year ago.
AGH has a better debt/assets ratio than last year.
AGH Yearly Shares OutstandingAGH Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M 8M 10M
AGH Yearly Total Debt VS Total AssetsAGH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1M 2M 3M 4M 5M

2.2 Solvency

An Altman-Z score of 21.17 indicates that AGH is not in any danger for bankruptcy at the moment.
AGH has a Altman-Z score of 21.17. This is amongst the best in the industry. AGH outperforms 99.24% of its industry peers.
There is no outstanding debt for AGH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 21.17
ROIC/WACCN/A
WACC9.04%
AGH Yearly LT Debt VS Equity VS FCFAGH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 200K 400K 600K 800K 1M

2.3 Liquidity

AGH has a Current Ratio of 9.35. This indicates that AGH is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 9.35, AGH belongs to the top of the industry, outperforming 98.47% of the companies in the same industry.
A Quick Ratio of 9.28 indicates that AGH has no problem at all paying its short term obligations.
AGH's Quick ratio of 9.28 is amongst the best of the industry. AGH outperforms 98.47% of its industry peers.
Industry RankSector Rank
Current Ratio 9.35
Quick Ratio 9.28
AGH Yearly Current Assets VS Current LiabilitesAGH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 1M 2M 3M

More info and screens

1

3. Growth

3.1 Past

AGH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -160.79%.
The Revenue has decreased by -7.21% in the past year.
The Revenue has been growing by 11.03% on average over the past years. This is quite good.
EPS 1Y (TTM)-160.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7%
Revenue 1Y (TTM)-7.21%
Revenue growth 3Y11.03%
Revenue growth 5YN/A
Sales Q2Q%-14.5%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AGH Yearly Revenue VS EstimatesAGH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 1M 2M 3M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

AGH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AGH Price Earnings VS Forward Price EarningsAGH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AGH Per share dataAGH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AGH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AUREUS GREENWAY HOLDINGS INC

NASDAQ:AGH (8/29/2025, 8:05:42 PM)

After market: 4.44 +0.1 (+2.3%)

4.34

+0.77 (+21.57%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.36%
Inst Owner Change56.05%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap63.41M
AnalystsN/A
Price TargetN/A
Short Float %1%
Short Ratio0.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 20.63
P/FCF N/A
P/OCF N/A
P/B 5.64
P/tB 5.64
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.21
BVpS0.77
TBVpS0.77
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.94%
ROE -2.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.03%
FCFM N/A
ROA(3y)4.05%
ROA(5y)N/A
ROE(3y)17.5%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.76%
GM growth 5YN/A
F-Score2
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 20.6%
Cap/Sales 1.35%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.35
Quick Ratio 9.28
Altman-Z 21.17
F-Score2
WACC9.04%
ROIC/WACCN/A
Cap/Depr(3y)111.46%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.94%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-160.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.21%
Revenue growth 3Y11.03%
Revenue growth 5YN/A
Sales Q2Q%-14.5%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-171.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-106.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-89.42%
OCF growth 3Y-38.05%
OCF growth 5YN/A